Christine Jones
University of Southampton
Research areas: Immunology and Microbiology · Microbiology · Neonatal and Maternal Infections · Bacterial Infections and Vaccines · Vaccine Coverage and Hesitancy
0000-0003-1523-2368
About
Professor Chrissie Jones is Professor of Paediatric Immunity and Infection at the University of Southampton, Honorary Consultant in Paediatric Infectious Diseases at University Hospital Southampton, and Co-Director of the IMPRINT global maternal and infant immunisation network.
Her research focuses on preventing infections during pregnancy and early life through vaccination and behavioural modifications, including congenital cytomegalovirus, group B streptococcus, pertussis and respiratory syncytial virus.
She has led multiple national and international vaccine clinical trials in pregnancy and serves as Medical Advisor to the charity CMV Action.
She also leads the Wessex perinatal infection service and has played a key role in advancing research, policy and public awareness around vaccination in pregnancy and congenital infection prevention.
Employment
-
University of Southampton Professor
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (133)
- The next generation of maternal vaccines: scientific advances, regulatory readiness, and strategic planning in Europe Save
- Clinical characteristics and factors contributing to transmission of congenital syphilis in England, 2015–24: a national surveillance study Save
- Preterm infants: immunity and immunisation Save
- Human Cytomegalovirus (HCMV) Shedding and T-cell Immune Responses in HCMV-seropositive Women During Pregnancy and Postpartum: Prevalence, Natural History, and Risk Factors Save
- Microbiome research in practice: priorities for clinical translation and impact Save
- Immunogenicity and safety of a group B Streptococcus vaccine (GBS-AlpN) in pregnant women and their infants: a phase 2, multicentre, observer-blind, randomised, placebo-controlled study Save
- An observational, cohort, multi-centre, open label phase IV extension study comparing IPV immune responses to preschool dTaP-IPV booster vaccines in children whose mothers received or did not receive an IPV-containing pertussis vaccine during pregnancy i… Save
- The impact of congenital cytomegalovirus infection among families and caregivers Save
- Heterologous COVID-19 vaccine schedule with protein-based prime (NVX-CoV2373) and mRNA boost (BNT162b2) induces strong humoral responses: results from COV-BOOST trial Save
- Vaccination in pregnancy to protect the newborn Save
- A template tool for the evaluation of vaccines for emerging pathogens to be used for pregnant and breast-feeding women Save
- Pertussis antibody responses in infants born to mothers vaccinated at different time points in pregnancy Save
- Controlled human infection model of Neisseria lactamica in late pregnancy investigating mother-to-infant transmission in the UK: a single-arm pilot trial Save
- Microbiotoxicity: a call to arms for cross-sector protection of the human microbiome Save
- Fostering Collaboration Across Nations: Report of the 6th International Neonatal and Maternal Immunization Symposium (INMIS), Costa Rica, 2024 Save
- Immunizing Pregnant Women and Infants (IMPRINT) Network: building and sustaining an interdisciplinary network tackling the complex challenges of vaccination in pregnancy and early life Save
- Protecting Against Respiratory Syncytial Virus: An Online Questionnaire Study Exploring UK Parents’ Acceptability of Vaccination in Pregnancy or Monoclonal Antibody Administration for Infants Save
- Burden of Lassa fever disease in pregnant women and children and options for prevention Save
- An open label, phase IV randomised controlled trial of two schedules of a four-component meningococcal B vaccine in UK preterm infants Save
- Postpartum interventions to increase maternal vaccination uptake: is it worth it? Save